Sign in

CIK 0001636651 · Non-accelerated filer<br>Smaller reporting company

Ovid Therapeutics Inc.

Sign in to watch
Ticker
OVID
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
465270895
Phone
212-776-4381
Business address
441 NINTH AVENUE, 14TH FLOOR, NEW YORK, NY, 10001
  1. CORRESP Other Correspondence Between Filers and SEC Staff
  2. SCHEDULE 13G Stake Statement of Beneficial Ownership
  3. 4 Insider Changes in Ownership
  4. SCHEDULE 13G Stake Statement of Beneficial Ownership
  5. 8-K Event Other events
  6. S-3 Offering Registration Statement
  7. 8-K Event Shareholder vote results
  8. 4 Insider Changes in Ownership
  9. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  10. SCHEDULE 13G Stake Statement of Beneficial Ownership
  11. 10-Q Report Quarterly Report
  12. 8-K Event Results of operations · Executive or director change
  13. DEF 14A Proxy Proxy Statement
  14. PRE 14A Proxy Proxy Statement (Preliminary)
  15. PREM14A Deal PREM14A
  16. 8-K Event Material agreement · Unregistered share sale · Bylaws or fiscal year change · Other events
  17. 8-K Event Other events
  18. 10-Q Report Quarterly Report
  19. 8-K Event Exhibits
  20. SCHEDULE 13G/A Stake Statement of Beneficial Ownership

Page 4 of 27 · 535 filings